Skyscape Web Viewer : Pharmacy Practice and the Law : Main Index

View All
consultant pharmacists Harder v. F. C. Clinton, Inc. Labeling of Drugs and Biologicals
consumer information
consumer medication information (CMI)
Consumer Product Safety Commission (CPSC)
Consumer Value Stores (CVS)
continuing education programs
continuing pharmacy education (CPE)
continuous quality improvement (CQI) programs An Alternative Approach to Regulation Continuous Quality Improvement Programs as Risk Management
contraceptives, emergency (Plan B)
contract pharmacies
contraindications, labels
contributory negligence
Controlled Substance Ordering System (CSOS)
Controlled Substance Registrant Protection Act (1984)
Controlled Substances Act (CSA)
controlled substances distribution Anabolic Steroids Act (2004) authority for scheduling Chemical Diversion and Trafficking Act (1988) Combat Methamphetamine Epidemic Act (2005) Controlled Substance Registrant Protection Act (1984) manufacturer labeling and packaging Methamphetamine Prevention Act (2008) Narcotic Addict Treatment Act (1974) overview U.S. Postal Laws
corporate negligence
corporate officer liability
correcting
corrections to prescriptions
corresponding responsibility doctrine Purpose of a Controlled Substance Prescription United States v. Hayes
cosmetics drugs vs. Drugs vs Cosmetics FDA definitions, overview FDA regulations federal regulations, overview prohibited acts, penalties, and enforcement, FDCA
cost concerns, Medicaid reimbursement
counseling patients
counterfeit drugs Corporate Officer Liability Defining and Distinguishing Drugs from Foods, Dietary Supplements, Devices, and Cosmetics Prescription Drug Marketing Act of 1987
courts, law made by
covered entities 340B Drugs Health Insurance Portability and Accountability Act of 1996 Use and Disclosure of PHI; Right to Access
See continuing pharmacy education (CPE) Continuing Education Licensing Licensing of Pharmacists See continuing pharmacy education (CPE) Standards of Practice
See Compliance Policy Guide (CPG) Bibliography FDA 1992 Compliance Policy Guide: Later Rescinded by FDAMA FDAMA's Compounding Provisions (§ 503A): Later Reinstated as § 503A Under the DQSA Inspections Under the Federal Food, Drug, and Cosmetic Act Marketed Unapproved Drugs Pharmacy Compounding vs Manufacturing Prescription Drug Labels and Labeling Prescription Drug Marketing Act of 1987 See Compliance Policy Guide (CPG) United States v. Hiland
See continuous quality improvement (CQI) programs Continuous Quality Improvement Programs Continuous Quality Improvement Programs as Risk Management Nelms v. Walgreen Co. Regulation for Outcomes Risk Management Strategies See continuous quality improvement (CQI) programs The Pharmacist as Risk Manager Walgreen Co. v. Selcke